Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Scand J Urol ; 55(1): 27-32, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33380254

ABSTRACT

OBJECTIVE: To evaluate if MRI/ultrasound fusion based targeted biopsy (FBx) leads to a reduced rate of change in Gleason score (GS) compared to prostatectomy specimen. METHODS: The histopathological findings of the biopsy of the prostate and the radical prostatectomy (RP) specimen of 210 patients who were referred to our hospital between 2012 and 2017 were compared retrospectively in this study. One hundred and five patients who underwent FBx combined with ultrasound-guided 12-core biopsy of the prostate (SBx) were matched with 105 patients who underwent SBx only. This study evaluated the rate of up- or downgrading in the RP specimen in both groups and compared the results via matched pair analysis. RESULTS: Concordance in Gleason grade group (GGG) was found in 52/105 patients (49.5%) in SBx and in 49/105 patients (46.7%) with FBx (p = 0.679). The rate of downgrading was statistically significant (p = 0.014) and was higher in the FBx group (14/105 patients, 13.3%) than in the SBx group (4/105 patients, 3.8%). A higher rate of upgrading was seen in SBx (49/105 patients; 46.7%) compared to FBx (42/105 patients; 40%), with no statistical significance (p = 0.331). The change in GGG from biopsy to final pathology in patients with GGG 1 and 2 at biopsy level was not statistically significant (p = 0.168). CONCLUSION: FBx does not decrease the rate of upgrading between biopsy and final pathology in RP specimens. Our results indicate that FBx tends to overestimate the final GGG compared to SBx.


Subject(s)
Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Aged , Biopsy, Large-Core Needle , Humans , Image-Guided Biopsy , Magnetic Resonance Imaging , Male , Matched-Pair Analysis , Middle Aged , Neoplasm Grading , Postoperative Period , Retrospective Studies , Ultrasonography, Interventional
2.
Sci Rep ; 10(1): 14017, 2020 08 20.
Article in English | MEDLINE | ID: mdl-32820238

ABSTRACT

Discarding by fisheries is one of the most wasteful human marine activities, yet we have few estimates of its scale. Reliable estimates of global discards are essential for sustainable fisheries management. Using United Nations Food and Agriculture Organization databases on country-specific landings, we estimated the discard rate and magnitude for global marine and estuarine capture fisheries using fishery-specific discard rates derived from direct observations and global gear-specific discard rates estimated within a Bayesian modelling framework. An estimated 9.1 million tonnes are discarded annually (95% uncertainty interval: 7-16 M t)-or 10.8% of the global catch (95% UI: 10-12%). Encouragingly, this is about half of the annual global discard rate estimated in the late 1980s. Trawl fisheries, especially demersal otter trawls, warrant intensified efforts to reduce discards. Periodic benchmarks of global discards are needed to assess the performance of reduction efforts.

3.
Clin Hemorheol Microcirc ; 74(1): 1-12, 2020.
Article in English | MEDLINE | ID: mdl-31743990

ABSTRACT

PURPOSE: The evaluation of the potential clinical benefit of four-dimensional ultrasound (4D-US) in the assessment of bladder cancer (BC). MATERIAL AND METHODS: 20 patients with indication for cystoscopy for suspicion of bladder cancer were prospectively included in this study. All patients underwent two-dimensional ultrasound (2D-US), contrast enhanced ultrasound (CEUS) and real-time four-dimensional ultrasound (4D-US). All acquisitions were compared to each other in regard to image quality. This assessment was done using a 6 point scale (1 = best). All patients underwent subsequently cystoscopy with resection of the tumor (TURB), due a histopathological analysis was possible. RESULTS: All examinations were performed successfully and no patient had to be excluded from the study. Patients acceptance of 4D-US was consistently good. No adverse events occurred. Image quality of real time 4D-US (score: 1.27±0.46) was significantly superior (p < 0.001) to both, conventional 2D-US (score: 2.33±0.62) and also to 2D-CEUS (score: 2.00±0.53). In terms of tumor detection no superiority was evident for 4D-US compared to 2D-US or in utilization of CEUS (sensitivity = 0.89; specificity = 1.00; positive predictive value = 1.00; negative predictive value = 0.50; AUC = 0.944; (95% CI: 07.43-0.998)). CONCLUSION: The assessment of bladder cancer using real time 4D-US is feasible and improves the image quality and therefore also the precise anatomical consistency of intravesical tumor masses.


Subject(s)
Contrast Media/therapeutic use , Four-Dimensional Computed Tomography/methods , Ultrasonography/methods , Urinary Bladder Neoplasms/diagnostic imaging , Aged , Female , Humans , Male , Middle Aged , Prospective Studies
4.
Clin Hemorheol Microcirc ; 73(1): 105-111, 2019.
Article in English | MEDLINE | ID: mdl-31561351

ABSTRACT

INTRODUCTION: Multiparametric-Magnetic Resonance Imaging (mpMRI)-Ultrasound fusion guided biopsy (Fbx) has emerged as the new standard of risk stratification for prostate cancer (PCa) with superior detection rates of clinically significant PCa than randomized biopsy. In the present study, we evaluated patients with suspicion of clinically significant PCa on mpMRI, but histopathologically proven Gleason 6 PCa in Fbx. MATERIAL AND METHODS: Between 2015 and 2019, 849 patients underwent Fbx and concurrent systematic 12-core biopsy at our department. 234 patients were diagnosed with Gleason 6 PCa in either mpMRI-targeted and/or concurrent systematic biopsy. Patients were analyzed regarding PSA, mpMRI findings according to PI-RADS classification, histopathological results of Fbx and systematic 12-core biopsy. 99/234 patients were also analyzed in regards of histopathology of the whole-mount specimen of subsequent radical prostatectomy (RP). RESULTS: In 131/234 patients (56%), Gleason 6 PCa was detected in the mpMRI target. In 103/234 patients (44%), Gleason 6 PCa was detected in the concurrent systematic 12-core biopsy with negative mpMRI-targeted biopsy. Men with evidence of Gleason 6 in the mpMRI target had significantly higher amounts of overall positive biopsies (median 4 vs. 2, p < 0.001) and higher maximum tumor infiltration per biopsy core (30% vs. 20%, p < 0.001) compared to men with negative mpMRI-targeted biopsy. Detection of Gleason 6 in mpMRI Target lesions correlated significantly with the PI-RADS score (p < 0.001). Patients with positive mpMRI-target had significantly higher tumor infiltration in whole-mount specimen after prostatectomy (20% vs. 15%, p = 0.0026) compared to men without detection of Gleason 6 in mpMRI-targeted biopsy but in additional systematic biopsy. CONCLUSION: Detection of Gleason 6 PCa in mpMRI-targeted biopsy indicates higher tumor burden compared to detection of Gleason 6 PCa in concurrent systematic biopsy and negative mpMRI-targeted biopsy.


Subject(s)
Image-Guided Biopsy/methods , Multiparametric Magnetic Resonance Imaging/methods , Neoplasm Grading/methods , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/diagnosis , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Prostatic Neoplasms/pathology
5.
Clin Hemorheol Microcirc ; 73(1): 135-143, 2019.
Article in English | MEDLINE | ID: mdl-31561350

ABSTRACT

INTRODUCTION: Focal therapy (FT) of the prostate for low risk prostate cancer (PCa) is an alternative to traditional definite treatment options like external beam radiotherapy or radical prostatectomy. However, follow up after FT is still challenging and is subject to current studies. Significance of imaging after FT such as multiparametric MRI (mpMRI) is currently not well established. In this study, we aimed to evaluate the efficacy of alternative imaging during the follow up of low risk PCa treated with focal HIFU therapy using CEUS and image fusion. MATERIALS AND METHODS: Retrospective single arm study in patients with uni- or bilateral, low or intermediate risk prostate cancer treated with HIFU at our institution between October 2016 and January 2018. CEUS in combination with image fusion using an axial T2-weighted MRI sequence was performed during follow up 3, 6, 9 and 12 months after the therapy. RESULTS: 4 consecutive patients with Gleason score (GS) 6 and 4 patients with GS 7a prostate cancer were included in the study. Hemiablation was performed in 7 patients with unilateral tumor. One patient underwent whole gland treatment due to histological proven bilateral PCa. Mean patient age at time of therapy was 70.3 (54-83) years and mean Prostate-specific antigen (PSA) level prior treatment was 7.8 ng/ml (2.1-14.4), after 3 months mean PSA level was 3.9 ng/ml (0.1-7.2), after 6 months 3.5 ng/ml (0.2-6.0), after 9 months 3.1 ng/ml (0.2-6.8) and 3.3 ng/ml (0.2-6.1) after 12 months. CEUS showed no signs of microvascularisation after 3, 6, 9 and 12 months in the ablated zone. 3 months posttreatment the necrotic tissue was still visible in the B-mode scan, although with no signs of vascularization performing CEUS. After 6 months the ablated side of the prostate was almost completely atrophic. And after 9 months the necrotic tissue was completely resolved. Between 9 and 12 months no changes in microvascularisation and perfusion could be shown. CONCLUSIONS: MpMRI/CEUS image fusion is a cost-effective and feasible technique to monitor the perfusion of the ablation zone after focal therapy of the prostate.


Subject(s)
High-Intensity Focused Ultrasound Ablation/methods , Magnetic Resonance Imaging/methods , Prostatic Neoplasms/diagnostic imaging , Ultrasonography/methods , Aged , Aged, 80 and over , Follow-Up Studies , Humans , Male , Middle Aged , Prostatic Neoplasms/pathology , Retrospective Studies
6.
Urologe A ; 58(5): 524-528, 2019 May.
Article in German | MEDLINE | ID: mdl-30859231

ABSTRACT

In the prostate-specific antigen (PSA) era, most prostate cancers (PCa) are diagnosed in a localized stage and a plethora of therapeutic options are warranted in different clinical settings and disease stages of localized PCa. In the current narrative review, we give an overview of the current controversies in the therapeutic landscape of localized PCa and focus on organ-sparing approaches, percutaneous radiotherapy, brachytherapy as well as retropubic and robot-assisted prostatectomy by summarizing studies that have been published within the last two years.


Subject(s)
Brachytherapy/methods , Prostatectomy/methods , Prostatic Neoplasms/therapy , Biopsy , Humans , Male , Prostate-Specific Antigen/blood , Prostatic Neoplasms/pathology
7.
Urologe A ; 58(3): 329-340, 2019 Mar.
Article in German | MEDLINE | ID: mdl-30824971

ABSTRACT

Prostate cancer is a heterogeneous disease. In cases of low-risk prostate cancer, active surveillance represents an attractive alternative treatment. Significant complications of a definitive treatment can therefore be delayed or completely avoided. Despite strict inclusion criteria for active surveillance, the diagnosis of low-risk prostate cancer can be inaccurate and there is therefore a risk of missing the optimal point in time for definitive treatment. Multimodal diagnostics and continuous aftercare are therefore crucial.


Subject(s)
Image-Guided Biopsy , Prostatic Neoplasms , Humans , Magnetic Resonance Imaging , Male , Multimodal Imaging , Prostatic Neoplasms/diagnostic imaging , Watchful Waiting
8.
Urologe A ; 58(2): 197-206, 2019 Feb.
Article in German | MEDLINE | ID: mdl-30734059

ABSTRACT

Ureteral injuries account for less than 3% of genitourinary injuries. Most of them are caused iatrogenically during abdominal surgery. The symptoms are often non-specific and do not aid in diagnosis. The later the injury is detected, the more often complications occur. Therefore, in such situations it is important to consider the possibility of ureteral injury and initiate further diagnostic steps as soon as possible. A variety of diagnostic tests are available. In addition to the direct inspection of the ureters and retrograde ureteropyelography, computed tomography (CT) urography is routinely used. Based on the time of diagnosis as well as the extent and the localization of the injury, the further procedure can be determined. For minor injuries, the insertion of a ureteral splint is usually the treatment of choice. In the case of higher grade damage, operative reconstruction by one of several possible surgical procedures is indicated.


Subject(s)
Ureter , Humans , Iatrogenic Disease , Stents , Tomography, X-Ray Computed , Ureter/diagnostic imaging , Ureter/injuries , Urography
9.
Clin Hemorheol Microcirc ; 71(2): 165-170, 2019.
Article in English | MEDLINE | ID: mdl-30562897

ABSTRACT

INTRODUCTION: We aimed to evaluate whether PIRADS 3 lesions in multiparametric MRI (mpMRI) represent a significant risk of prostate cancer (PCa) in a real-world setting of different referring radiologic institutes. MATERIALS AND METHODS: Between May 2015 and October 2017, a total of 408 patients were referred to our clinic for MRI-ultrasound fusion targeted biopsy of the prostate (FusPbx) due to suspected prostate cancer. In all patients, preoperatively an mpMRI of the prostate was performed by altogether 62 different radiologic institutes. Prostate lesions were classified according to the PIRADS system. A PIRADS 3 lesion was diagnosed in 41 patients. FusPbx was performed transrectally using a Philips EPIQ 7 (Philips Medical Systems, Bothell, WA) scanner with plane wise fusion of ultrasound and MRI image data. In addition to FusPbx in each patient a randomized 12-core transrectal ultrasound guided biopsy (USPbx) was performed. RESULTS: Mean PSA Level was 9.5 ng/ml (range: 1- 26 ng/ml), mean patients age was 66.1 years (48.6- 80.4). In 11/41 patients (26.8%) prostate cancer was diagnosed by FusPbx of the PIRADS 3 lesion. In the target lesion PCa was classified as Gleason Score 3+3 in 5 patients, as 3+4 in 3, 4+3 in 1, 4+4 in 1 and 4+5 in 1 patient. In patients with negative FusPbx USPbx revealed PCa in another 7 patients (17.1%). In 5 of these GS 3+3 PCa was found, in another 2 patients GS 3+4 PCa. CONCLUSIONS: PIRADS 3 lesion indicates an equivocal likelihood of significant prostate cancer. In our series the overall PCa detection rate was 26.8% and 14.6% for clinically significant cancer in PIRADS 3 lesions. This evokes the question, if PIRADS 3 lesions could be surveilled only. The findings should be confirmed in a larger series.


Subject(s)
Magnetic Resonance Imaging/methods , Prostate/diagnostic imaging , Prostatic Neoplasms/diagnostic imaging , Aged , Aged, 80 and over , Humans , Image-Guided Biopsy/methods , Male , Middle Aged , Prostate/pathology , Prostatic Neoplasms/pathology
10.
Urologe A ; 57(1): 29-33, 2018 Jan.
Article in German | MEDLINE | ID: mdl-29209754

ABSTRACT

BACKGROUND: The development of a stricture of the vesicourethral anastomosis is a serious complication after radical prostatectomy. Strictures occur in 5-8% of patients after radical prostatectomy. SYMPTOMS: Usually the clinical symptoms include an irritative and obstructive component similar to benign prostatic hyperplasia. In rare cases, patients suffer from partial or complete stress incontinence as a result of the anastomotic stricture. DIAGNOSTICS: The diagnostic workup is similar to the procedure for urethral strictures. In addition to uroflowmetry, a cystourethrogram (CUG) or, if necessary, a micturating cystourethrogram (MCU) can be performed. A urethrocystoscopy can be performed to ensure the diagnosis. THERAPY: In most cases, endoscopic procedures were performed for treatment. Beside a transurethral dilation of the stricture or the Sachse urethrotomy, the most common procedure is transurethral resection to treat the stricture. However, all procedures are associated with a high recurrence rate. In recurrent strictures, open surgical procedures, usually a perineal reanastomosis, should performed early. CONCLUSION: Endourological procedures like transurethral resection are a good treatment option, but due to the high recurrence rates, open surgical procedures should be discussed and if necessary should be performed early.


Subject(s)
Anastomosis, Surgical , Prostatectomy/adverse effects , Prostatectomy/methods , Urethral Stricture/etiology , Urethral Stricture/therapy , Adenocarcinoma/diagnosis , Adenocarcinoma/surgery , Anastomosis, Surgical/adverse effects , Constriction, Pathologic , Humans , Male , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/surgery , Urethra
11.
Urologe A ; 57(1): 6-10, 2018 Jan.
Article in German | MEDLINE | ID: mdl-29189873

ABSTRACT

Urethral stricture is a narrowing of the urethra due to scar tissue. It causes obstructive voiding dysfunction and can lead to long-term damage of the entire urinary tract. The probability of therapeutic success is dampened by a high rate of recurrence. Therefore, a careful taking of the patient's history and further diagnostics are crucial for finding the appropriate form of therapy. This review highlights the clinical presentation and diagnostic workup of urethral strictures.


Subject(s)
Urethral Stricture/diagnosis , Humans , Male , Recurrence , Urethra , Urethral Stricture/etiology
12.
Urologe A ; 56(11): 1430-1434, 2017 Nov.
Article in German | MEDLINE | ID: mdl-28983651

ABSTRACT

The resection of the primary tumor in patients with metastatic prostate cancer is controversially debated. Retrospective clinical studies indicate survival benefits and prevention of secondary, locoregional complications; however, results of ongoing multicenter prospective studies are still lacking. This review highlights the rationale behind the cytoreductive prostatectomy and summarizes current clinical study results.


Subject(s)
Bone Neoplasms/secondary , Bone Neoplasms/surgery , Cytoreduction Surgical Procedures/methods , Lymphatic Metastasis/pathology , Prostatectomy/methods , Prostatic Neoplasms/surgery , Bone Neoplasms/mortality , Bone Neoplasms/pathology , Combined Modality Therapy , Guideline Adherence , Humans , Male , Neoplasm Staging , Prostatic Neoplasms/mortality , Prostatic Neoplasms/pathology , Retrospective Studies
13.
Sci Total Environ ; 389(2-3): 539-44, 2008 Jan 25.
Article in English | MEDLINE | ID: mdl-17950431

ABSTRACT

The aim of this study was assessing whether trace metal bioaccumulation models for oysters need to account for the effect of size-structured demography. To achieve this, we used a Bayesian generalised additive mixed modelling (BGAMM) approach. This nonparametric regression approach allowed us to estimate potentially nonlinear size effects of the oysters as well as random and structured spatial effects. Native oysters were collected from ten locations around the shoreline of Moreton Bay, a subtropical estuary in southeast Queensland, Australia. The soft-tissue of these sampled oysters were weighed (dry weight basis) and then analysed for Al, Cu, Fe, Mg, Mn and Zn. Of the six trace metals analysed, only Mg was found to have a significant (negative) effect of soft-tissue mass. The correlated spatial effects for Cu, Mn and Zn indicated that the source of these trace metals in the oysters was from anthropogenic inputs while the correlated spatial effects for Al and Mg indicated natural inputs. The correlated spatial effect for Fe was characterised by 'hotspot' concentrations in regions of Moreton Bay where algal blooms have previously occurred and consequently oysters might be useful as an indicator of algal blooms in the Bay. Overall, the absence of an observed size effect for five of the six trace metals indicates that bioaccumulation models do not necessarily need to account for size-structured demography therefore enabling simpler models to be used.


Subject(s)
Environmental Monitoring/methods , Models, Statistical , Ostreidae/metabolism , Trace Elements/pharmacokinetics , Animals , Bayes Theorem , Body Size , Environmental Monitoring/statistics & numerical data , Ostreidae/growth & development , Queensland , Statistics, Nonparametric , Tissue Distribution , Trace Elements/analysis
14.
Public Health Rep ; 110(3): 240-5, 1995.
Article in English | MEDLINE | ID: mdl-7610210

ABSTRACT

The "Rating the States" (RTS) Program of Mothers Against Drunk Driving (MADD) is designed to bring public attention to the status of State government efforts to combat alcohol-impaired driving. MADD's 1993 report, which evaluated each State with a grade from A to D, brought renewed visibility to MADD's fight for new prevention policies and helped to advance key State legislation. Because of MADD's national press conference and other media activities, more than 60 million Americans saw or heard a news story related to the program. This article outlines the program's objectives and methodology, efforts to publicize the results, and what was achieved in terms of news media coverage and in advancing public policy change. The RTS Program is a proven media advocacy strategy for prompting State legislatures and Governors to enact new policies. The article concludes with guidelines for other public health advocacy groups that may want to emulate this strategy.


Subject(s)
Accidents, Traffic/prevention & control , Alcoholic Intoxication , Consumer Advocacy , Information Services , Public Relations , Accidents, Traffic/legislation & jurisprudence , Consumer Organizations , Humans , Mass Media , Public Policy , Surveys and Questionnaires , United States
15.
J Neurosci Nurs ; 26(2): 103-6, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8077770

ABSTRACT

Each year, thousands of preventable injuries occur in children as well as adults. Until recently, few programs existed to address injury prevention issues. Three programs which make a difference include The National Safe Kids Campaign, Think First and Mothers Against Drunk Driving. Each has a different focus and has opportunities for neuroscience nurses to become involved. Additional programs with measurable benefits need to be developed.


Subject(s)
Primary Prevention/organization & administration , Voluntary Health Agencies/organization & administration , Wounds and Injuries/prevention & control , Adult , Child , Humans , United States/epidemiology , Wounds and Injuries/epidemiology
16.
Fed Proc ; 43(2): 181-4, 1984 Feb.
Article in English | MEDLINE | ID: mdl-6692937

ABSTRACT

The analysis of multiple-indicator dilution curves to estimate the rates of transport of ions and substrates across the sarcolemma of myocardial cells requires the formulation of models for the blood-interstitial fluid-cell exchanges. The fitting of models to the sets of experimental data is dependent on acquiring a large enough data set, in one physiological state, that there is at least as much information in the data as there are unknown model parameters to be determined. Inasmuch as data are necessarily noisy, redundancy of data and overdetermination of the unknowns are highly desirable. Sensitivity functions are useful in demonstrating which portions of the data relate to which unknown parameters. They are also useful in adjusting model parameters to fit the model to the data, and therefore in parameter evaluation.


Subject(s)
Biological Transport , Models, Biological , Blood Flow Velocity , Capillary Permeability , Cell Membrane Permeability , Coronary Circulation , Myocardium/metabolism , Research Design
17.
Math Comput Simul ; 24(6): 502-506, 1982 Dec.
Article in English | MEDLINE | ID: mdl-21760658

ABSTRACT

The analysis of multiple indicator dilution curves to estimate the rates of transport of ions and substrates across the sarcolemma of myocardial cells requires the formulation of models for the blood-ISF-cell exchanges. The fitting of models to the sets of experimental data is dependent of acquiring a large enough data set, in one physiological state, that there is at least as much information in the data as there are unknown model parameters to be determined. Since data are necessarily noisy, redundancy of data and overdetermination of the unknowns is highly desirable. Sensitivity functions are useful in demonstrating which portions of the data relate to which unknown parameters. They are also useful in adjusting model parameters to fit the model to the data, and therefore in parameter evaluation.

SELECTION OF CITATIONS
SEARCH DETAIL
...